Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 1551 - 1600 of 4862 results
- Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients.
- The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors.
- Catechin derivatives: specific inhibitor for caspases-3, 7 and 2, and the prevention of apoptosis at the cell and animal levels.
- Investigation of mechanism-based thrombin inhibitors: Implications of a highly conserved water molecule for the binding of coumarins within the S pocket.
- Factor VIIa inhibitors: gaining selectivity within the trypsin family.
- Erectile dysfunction and subsequent cardiovascular disease.
- Searching for the molecular arrangement of transmembrane ceramide channels.
- Estrogen receptor-alpha mediates acute myocardial protection in females.
- Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload.
- Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart.
- The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
- Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts.
- The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43.
- Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.
- Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure.
- Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
- Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study.
- An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice.
- Sepsis in European intensive care units: results of the SOAP study.
- Role of tumor necrosis factor-alpha in myocardial dysfunction and apoptosis during hindlimb ischemia and reperfusion.
- Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice.
- Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
- Prediction of hERG potassium channel affinity by the CODESSA approach.
- Histidine button engineered into cardiac troponin I protects the ischemic and failing heart.
- Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.
- Polyamines are potent ligands for the capsaicin receptor TRPV1.
- Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.
- Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist.
- Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.
- Long-term follow-up of changes in fibrillation waves in patients with persistent atrial fibrillation: spectral analysis of surface ECG.
- Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension.
- Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model.
- Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction.
- Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib).
- Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses.
- Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival.
- The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
- Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines.
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
- Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
- CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities.
- Connexin43-dependent mechanism modulates renin secretion and hypertension.
- Sildenafil extends survival and graft function in a large animal lung transplantation model.
- Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.
- Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
- Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?
- Intracellular targeting of truncated secretory peptides in the mammalian heart and brain.
- ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
- Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.
- Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >